Neurogene NGNE
NASDAQ NGNE
$23.55 -0.73 (-3.01%)
At close: Oct 23, 2026 · 4:00 PM EDT

Neurogene (NGNE) Amortization of Deferred Charges (2014 - 2026)

Updated

Analysis

Neurogene (NGNE) Amortization of Deferred Charges (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Neurogene 532.34 Mn -470.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7,000.00
Mar 31, 2026 7,000.00
Dec 31, 2025 11,000.00
Sep 30, 2025 12,000.00
Jun 30, 2025 12,000.00
Mar 31, 2025 13,000.00
Dec 31, 2024 13,000.00
Sep 30, 2024 12,000.00
Jun 30, 2024 17,000.00
Mar 31, 2024 11,000.00
Dec 31, 2023 11,000.00
Sep 30, 2023 10,000.00
Jun 30, 2023 8,000.00
Mar 31, 2023 6,000.00
Mar 31, 2014 320,000.00
API Access

Neurogene Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=NGNE&period=max&api_key=YOUR_API_KEY